Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

We initiated a prospective multicenter phase II trial using rituximab and temozolomide in immunocompetent patients with progressive or recurrent primary central nervous system lymphoma (PCNSL) based on activity observed in retrospective studies. Treatment consisted of an induction phase with rituxim...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Leuk Lymphoma
Autori principali: Nayak, Lakshmi, Abrey, Lauren E., Drappatz, Jan, Gilbert, Mark R., Reardon, David A., Wen, Patrick Y., Prados, Michael, Deangelis, Lisa M., Omuro, Antonio
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4802006/
https://ncbi.nlm.nih.gov/pubmed/22656234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2012.698736
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi